Cefprozil is a second-generation cephalosporin antibiotic used to treat various bacterial infections
In humans, Corbeil et al. showed that a 7-day exposure to cefprozil led to a loss of metagenome-defined species Elkrief et al. 2019 Annals of Oncology 30(10): 1572-1579
